IMU Biosciences raised €45M in a funding round in Jun 2026. The company is based in London, UK. Investors in the round: IQ Capital, Molten Ventures. Data as of 22 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
